文献速递重症综合管理与镇静镇痛

ICU地理分组模式对学术三级医疗中心的影响

Impact of Geographical Cohorting in the ICU: An Academic Tertiary Care Center Experience.
PubMed 文献 · Crit Care Explor · 2020-09-25
一句话结论在大型ICU实施地理分组查房可显著降低艰难梭菌感染、压力性损伤、中心线相关血流感染和导管相关尿路感染发生率,并改善医护协调与工作流程。

该研究为回顾性分析,评估某学术三级医疗中心130张床ICU实施地理分组查房模式前后12个月的质量指标。实施前后ICU患者天数、中心静脉导管日、导尿管日及ICU住院时间(4.9天)相似。实施后艰难梭菌感染(相对风险-0.50,95%CI 0.25-0.96,p=0.039)、医院获得性压力性损伤(相对风险-0.60,95%CI 0.39-0.92,p=0.020)、中心线相关血流感染(相对风险-0.19,95%CI 0.05-0.52,p=0.008)和导管相关尿路感染(相对风险-0.52,95%CI 0.29-0.93,p=0.027)发生率显著降低。医护人员认为地理分组查房优化了时间利用、减少了中断并改善了协调。

要点

  • 在130张床的ICU实施地理分组查房后,中心线相关血流感染相对风险降低至-0.19(95%CI 0.05-0.52,p=0.008)。
  • 实施地理分组后导管相关尿路感染相对风险为-0.52(95%CI 0.29-0.93,p=0.027)。
  • 医院获得性压力性损伤相对风险为-0.60(95%CI 0.39-0.92,p=0.020),艰难梭菌感染相对风险为-0.50(95%CI 0.25-0.96,p=0.039)。
  • 实施前后ICU住院时间均为4.9天,患者天数、中心静脉导管日及导尿管日相似。
  • 医护人员反馈地理分组查房优化了时间利用、减少了中断并改善了协调。

适用人群与场景

  • 所有收入该130张床ICU的患者。
  • 场景为学术三级医疗中心ICU。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 第一步:在ICU实施地理分组模式进行重症监护医师查房(2018年9月1日启动)。
  • 第二步:监测ICU伤害事件和ICU住院指标。
  • 第三步:实施12个月后对重症监护医护人员进行问卷调查。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为回顾性分析,评估地理分组实施前后12个月的质量指标;样本量为所有收入ICU的患者,单中心(130张床ICU)。
  • 主要结果:艰难梭菌感染相对风险-0.50(95%CI 0.25-0.96,p=0.039),医院获得性压力性损伤相对风险-0.60(95%CI 0.39-0.92,p=0.020),中心线相关血流感染相对风险-0.19(95%CI 0.05-0.52,p=0.008),导管相关尿路感染相对风险-0.52(95%CI 0.29-0.93,p=0.027)。
  • ICU住院时间实施前后均为4.9天;患者天数(实施前34,839 vs 实施后35,155)、中心静脉导管日(17,648 vs 19,224)、导尿管日(18,292 vs 17,364)相似。
  • 医护人员调查显示地理分组查房优化了时间利用、减少了中断并改善了协调。

证据类型、等级与局限

  • 证据类型为回顾性分析(原文自述retrospective analysis),单中心。
  • 原文未述局限性。

对床旁实践的改变

  • 在大型ICU中,地理分组查房模式可能降低艰难梭菌感染、压力性损伤、中心线相关血流感染和导管相关尿路感染的发生率。
  • 该模式可能改善医护协调和工作流程,减少中断并优化时间利用。
  • 原文未提及适用与不适用人群的明确标准。

指南或共识出处

  • Crit Care Explor

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: ICU is a multifaceted organization where multiple teams care for critically ill patients. In the current era, collaboration between teams and efficient workflows form the backbone of value-based care. Geographical cohorting is a widespread model for hospitalist rounding, but its role in ICUs is unclear. This study evaluates the outcomes of geographical cohorting in a large ICU of an Academic Health Center.

DESIGN: This is a retrospective analysis of quality metrics collected 12 months pre- and post-implementation of geographical cohorting.

SETTING: A total of 130 bedded ICU at tertiary academic health center in Midwest.

PATIENTS: All patients admitted to the ICU.

INTERVENTIONS: Our institution piloted the geographical cohorting model for critical care physician rounding on September 1, 2018.

MEASUREMENTS: The quality metrics were categorized as ICU harm events and ICU hospital metrics. Team of critical care providers were surveyed 12 months after implementation.

MAIN RESULTS: The critical care utilization in the pre- and post-implementation numbers were similar for patient days (pre = 34,839, post = 35,155), central-line days (pre = 17,648, post = 19,224), and Foley catheter days (pre = 18,292, post = 17,364). The ICU length of stay was similar (4.9 d) in both pre- and post-intervention periods. Significant reduction in the incidence of Clostridium difficile infection (relative risk, -0.50; 95% CI, 0.25-0.96; p = 0.039), hospital-acquired pressure injury (relative risk, -0.60; 95% CI, 0.39-0.92; p = 0.020), central line-associated bloodstream infection incidence (relative risk, -0.19; 95% CI, 0.05-0.52; p = 0.008), and catheter-associated urinary tract infection (relative risk, -0.52; 95% CI, 0.29-0.93; p = 0.027). Healthcare providers perceived optimal utilization of their time, reduced interruptions, and improved coordination of care with geographical rounding.

CONCLUSIONS: Geographical cohorting improves coordination of care, physician workflow, and critical care quality metrics in very large ICUs.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Kapoor R, Gupta N, Roberts SD, et al. Impact of Geographical Cohorting in the ICU: An Academic Tertiary Care Center Experience. Crit Care Explor. 2020. PMID: 33063024. doi:10.1097/CCE.0000000000000212

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。